Amgen ends Ideaya cancer combination trial after partner unveils rival molecule

cafead

Administrator
Staff member
  • cafead   Feb 13, 2025 at 10:02: PM
via Amgen and Ideaya Biosciences are winding down their cancer combination study, closing off one way the Big Biotech was looking to dial up the efficacy of its PRMT5 inhibitor AMG 193.

article source